Home
University of Bergen
Roald Omdal's picture

Roald Omdal

Guest Researcher
Department of Clinical Science
  • E-mailRoald.Omdal@uib.no
  • Visitor Address
    Haukeland universitetssykehus, Laboratoriebygget
    5009 Bergen
  • Postal Address
    Postboks 7804
    5020 Bergen
Academic article
  • Show author(s) (2024). Thyroidectomy for Euthyroid Patients with Hashimoto Disease and Persistent Symptoms: An Observational, Postrandomization Study. Journal of Thyroid Research. 7 pages.
  • Show author(s) (2024). Fatigue in Parkinson's Disease: A Proteomic Study of Cerebrospinal Fluid. Movement Disorders.
  • Show author(s) (2023). Thyroidectomy for Euthyroid Patients With Hashimoto Disease and Persisting Symptoms. Annals of Internal Medicine. 101-103.
  • Show author(s) (2023). Stratified genetic analysis reveals sex differences in MPO-ANCA-associated vasculitis. Rheumatology. 3213-3218.
  • Show author(s) (2023). Less, but not gone—gluten-free diet effects on fatigue in celiac disease: a prospective controlled study. Frontiers in medicine. 10 pages.
  • Show author(s) (2023). High mobility group box 1 and a network of other biomolecules influence fatigue in patients with Crohn’s disease. Molecular medicine (Cambridge, Mass. Print).
  • Show author(s) (2022). Strong association of combined genetic deficiencies in the classical complement pathway with risk of systemic lupus erythematosus and primary Sjögren's syndrome. Arthritis & Rheumatology. 1842-1850.
  • Show author(s) (2022). Genome-wide association study identifies Sjögren’s risk loci with functional implications in immune and glandular cells. Nature Communications. 1-17.
  • Show author(s) (2022). Fatigue: a frequent and biologically based phenomenon in newly diagnosed celiac disease. Scientific Reports. 10 pages.
  • Show author(s) (2022). Complement C4 Copy Number Variation is Linked to SSA/Ro and SSB/La Autoantibodies in Systemic Inflammatory Autoimmune Diseases. Arthritis & Rheumatology. 1440-1450.
  • Show author(s) (2021). The influence of disease activity on fatigue in patients with ulcerative colitis–a longitudinal study. Scandinavian Journal of Gastroenterology. 8 pages.
  • Show author(s) (2021). Sample Preparation Strategies for Antibody-Free Quantitative Analysis of High Mobility Group Box 1 Protein. Pharmaceuticals. 13 pages.
  • Show author(s) (2021). Neurofilament light in plasma is a potential biomarker of central nervous system involvement in systemic lupus erythematosus. Journal of Neurology. 11 pages.
  • Show author(s) (2021). Molecular pathways in patients with systemic lupus erythematosus revealed by gene-centred DNA sequencing. Annals of the Rheumatic Diseases. 109-117.
  • Show author(s) (2021). Identification and functional characterization of a novel susceptibility locus for small vessel vasculitis with MPO-ANCA. Rheumatology. 3461-3470.
  • Show author(s) (2021). Genetic variants at the RTP4/MASP1 locus are associated with fatigue in Scandinavian patients with primary Sjögren’s syndrome. RMD Open. 9 pages.
  • Show author(s) (2021). Fatigue and expression of heat shock genes in plaque type psoriasis. Clincal and Experimental Dermatology.
  • Show author(s) (2021). DNA Methylation-Based Interferon Scores Associate With Sub-Phenotypes in Primary Sjögren’s Syndrome. Frontiers in Immunology. 13 pages.
  • Show author(s) (2021). Anti-HMGB1 auto-Abs influence fatigue in patients with Crohn’s disease. Innate Immunity. 286-293.
  • Show author(s) (2020). Neurofilament light is a biomarker of brain involvement in lupus and primary Sjögren’s syndrome. Journal of Neurology. 10 pages.
  • Show author(s) (2020). Genetic and clinical basis for two distinct subtypes of primary Sjögren's syndrome. Rheumatology. 837-848.
  • Show author(s) (2020). Fatigue in patients with plaque-type psoriasis: lack of an association with plasma cytokines. EJD. European journal of dermatology. 16-23.
  • Show author(s) (2019). Tubulointerstitiell nefritt og uveittsyndrom. Tidsskrift for Den norske legeforening. 4 pages.
  • Show author(s) (2019). Tolerability and safety of long-term rituximab treatment in systemic inflammatory and autoimmune diseases. Rheumatology International. 1083-1090.
  • Show author(s) (2019). Thyroidectomy Versus Medical Management for Euthyroid Patients With Hashimoto Disease and Persisting Symptoms: A Randomized Trial. Annals of Internal Medicine. 453-464.
  • Show author(s) (2019). Severe headache in primary Sjögren's syndrome treated with intrathecal rituximab. Clinical Case Reports. 1-3.
  • Show author(s) (2019). Nasal and salivary pepsin as a biomarker for gastro-esophageal reflux in chronic rhinosinusitis. Rhinology Online. 25-31.
  • Show author(s) (2019). Malondialdehyde and advanced oxidation protein products are not increased in psoriasis: a controlled study. Archives of Dermatological Research. 299-308.
  • Show author(s) (2019). Interleukin-1-related activity and hypocretin-1 in cerebrospinal fluid contribute to fatigue in primary Sjögren's syndrome. Journal of Neuroinflammation. 1-9.
  • Show author(s) (2019). Heat-shock protein 90α in plasma reflects severity of fatigue in patients with Crohn’s disease. Innate Immunity. 146-151.
  • Show author(s) (2019). Fatigue in primary Sjögren's syndrome: A proteomic pilot study of cerebrospinal fluid. SAGE Open Medicine. 1-10.
  • Show author(s) (2019). Fatigue in Mastocytosis: A Case Series. Clinical Therapeutics. 625-632.
  • Show author(s) (2019). Determination of lower cut-off levels of adalimumab associated with biochemical remission in Crohn's disease. Journal of Gastroenterology and Hepatology Open (JGH Open). 1-7.
  • Show author(s) (2019). Considerably Lower Levels of Hypocretin-1 in Cerebrospinal Fluid Is Revealed by a Novel Mass Spectrometry Method Compared with Standard Radioimmunoassay. Analytical Chemistry. 9323-9329.
  • Show author(s) (2018). The blood-brain barrier, TWEAK, and neuropsychiatric involvement in human systemic lupus erythematosus and primary Sjögren's syndrome. Lupus. 2101-2111.
  • Show author(s) (2018). Subtherapeutic concentrations of infliximab and adalimumab are associated with increased disease activity in Crohn's disease. Therapeutic Advances in Gastroenterology. 1-11.
  • Show author(s) (2018). Heat shock protein 90 and inflammatory activity in newly onset Crohn’s disease. Scandinavian Journal of Gastroenterology. 1453-1458.
  • Show author(s) (2018). Fatigue is common and severe in patients with mastocytosis . International Journal of Immunopathology and Pharmacology. 1-4.
  • Show author(s) (2018). Biomarker Discovery for Diagnosis and Stratification. Clinical and Experimental Rheumatology. S-246.
  • Show author(s) (2017). Rare X chromosome abnormalities in systemic Lupus Erythematosus and Sjögren's Syndrome. Arthritis & Rheumatology. 2187-2192.
  • Show author(s) (2017). No structural cerebral MRI changes related to fatigue in patients with primary Sjögren’s syndrome. Rheumatology - Advances in Practice (Rheumap). 8 pages.
  • Show author(s) (2017). Long-term follow-up in primary Sjogren's syndrome reveals differences in clinical presentation between female and male patients. Biology of Sex Differences. 1-9.
  • Show author(s) (2017). Identification of a Sjögren's syndrome susceptibility locus at OAS1 that influences isoform switching, protein expression, and responsiveness to type I interferons. PLoS Genetics. 1-29.
  • Show author(s) (2017). Fatigue in psoriasis: a controlled study. British Journal of Dermatology. 505-512.
  • Show author(s) (2017). En kvinne i 60-årene med diare og leddsmerter. Tidsskrift for Den norske legeforening.
  • Show author(s) (2016). X chromosome dose and sex bias in autoimmune diseases: increased prevalence of 47,XXX in systemic Lupus Erythematosus and Sjögren's Syndrome. Arthritis & Rheumatology. 1290-1300.
  • Show author(s) (2016). TWEAK is not elevated in patients with newly diagnosed inflammatory bowel disease. Scandinavian Journal of Gastroenterology. 420-424.
  • Show author(s) (2016). Migraine in patients with systemic lupus erythematosus is associated with reduced cerebral grey matter volume but not with measures of glial activation or anti-NR2 or anti-P antibodies. European Journal of Neurology. 780-786.
  • Show author(s) (2016). Metabolomics study of fatigue in patients with rheumatoid arthritis naïve to biological treatment. Rheumatology International. 703-711.
  • Show author(s) (2016). Low protein A20 in minor salivary glands is associated with lymphoma development in primary Sjögren's syndrome. Scandinavian Journal of Immunology. 181-187.
  • Show author(s) (2016). Klinefelter's syndrome (47,XXY) is in excess among men with Sjögren's syndrome. Clinical Immunology. 25-29.
  • Show author(s) (2016). Heat shock proteins and chronic fatigue in primary Sjögren's syndrome. Innate Immunity. 162-167.
  • Show author(s) (2016). Genome-wide DNA methylation analysis in multiple tissues in primary Sjögren’s syndrome reveals regulatory effects at interferon-induced genes. Annals of the Rheumatic Diseases. 2029-2036.
  • Show author(s) (2016). Epigenome-wide DNA methylation patterns associated with fatigue in primary Sjögren's syndrome. Rheumatology. 1074-1082.
  • Show author(s) (2016). Conventional treatment regimens for ulcerative colitis alleviate fatigue – an observational cohort study. Scandinavian Journal of Gastroenterology. 1213-1219.
  • Show author(s) (2015). The IRF5-TNPO3 association with systemic lupus erythematosus has two components that other autoimmune disorders variably share. Human Molecular Genetics. 582-596.
  • Show author(s) (2015). Fatigue in Newly Diagnosed Inflammatory Bowel Disease. Journal - Crohn's and Colitis Foundation of Canada. 725-730.
  • Show author(s) (2015). A rapid method for preparation of the cerebrospinal fluid proteome. PROTEOMICS - Clinical Applications. 10-15.
  • Show author(s) (2014). Primary Sjögren's syndrome - fatigue is an ever-present, fluctuating and uncontrollable lack of energy. Arthritis Care and Research. 1227-1232.
  • Show author(s) (2014). Loss of cerebral white matter in primary Sjögren's syndrome: a controlled volumetric magnetic resonance imaging study. European Journal of Neurology. 1324-1329.
  • Show author(s) (2014). High headache-related disability in patients with systemic lupus erythematosus and primary Sjögren's syndrome. European Journal of Neurology. 1124-1130.
  • Show author(s) (2014). Genetic associations to germinal centre formation in primary Sjögren's syndrome. Annals of the Rheumatic Diseases. 1253-1258.
  • Show author(s) (2014). Evaluation of germinal center-like structures and B cell clonality in patients with primary Sjögren syndrome with and without Lymphoma. Journal of Rheumatology. 2214-2222.
  • Show author(s) (2014). Association of hippocampal atrophy with cerebrospinal fluid antibodies against the nr2 subtype of the N-methyl- D -aspartate receptor in patients with systemic lupus erythematosus and patients with primary Sjögren's syndrome. Arthritis and Rheumatism. 3387-3394.
  • Show author(s) (2014). A possible genetic association with chronic fatigue in primary Sjögren’s syndrome: a candidate gene study. Rheumatology International. 191-197.
  • Show author(s) (2013). Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjögren's syndrome. Nature Genetics. 1284-1292.
  • Show author(s) (2013). Tetradecylthioacetic acid attenuates inflammation and has antioxidative potential during experimental colitis in rats. Digestive Diseases and Sciences. 97-106.
  • Show author(s) (2013). Sjögren's syndrome: NCR3/NKp30 contributes to pathogenesis in primary Sjögren's syndrome. Science Translational Medicine.
  • Show author(s) (2013). Risk of non-Hodgkin's lymphoma in primary Sjögren's syndrome: a population-based study. Arthritis Care and Research. 816-821.
  • Show author(s) (2013). No association of primary Sjögren's syndrome with Fcγ receptor gene variants. Genes and Immunity. 234-237.
  • Show author(s) (2013). NCR3/NKp30 contributes to pathogenesis in Primary Sjögren's Syndrome. Science Translational Medicine. 10 pages.
  • Show author(s) (2013). Memory dysfunction in Primary Sjögren’s Syndrome is associated with anti-NR2 antibodies. Arthritis and Rheumatism. 3209-3217.
  • Show author(s) (2013). Headache in primary Sjøgren's syndrome: a population-based retrospective cohort study. European Journal of Neurology. 558-563.
  • Show author(s) (2013). Association of genes in the NF-kappa B pathway with antibody-positive Primary Sjögren's Syndrome. Scandinavian Journal of Immunology. 447-454.
  • Show author(s) (2013). A salmon peptide diet alleviates experimental colitis as compared with fish oil. Journal of Nutritional Science (JNS). 1-8.
  • Show author(s) (2012). The risk of Non-Hodgkin Lymphoma in Primary Sjögren's Syndrome, a population-based study. Arthritis Care and Research.
  • Show author(s) (2012). Oxidative stress, as measured by protein oxidation, is increased in primary Sjögren's syndrome. Free radical research. 141-146.
  • Show author(s) (2012). Interleukin-1 inhibition and fatigue in primary Sjögren's Syndrome - a double blind, randomised clinical trial. PLOS ONE. 429-435.
  • Show author(s) (2012). Improved detection of advanced oxidation protein products in plasma. Clinica Chimica Acta. 901-906.
  • Show author(s) (2012). Dietary supplementation of krill oil attenuates inflammation and oxidative stress in experimental ulcerative colitis in rats. Scandinavian Journal of Gastroenterology. 49-58.
  • Show author(s) (2012). Development of sarcoidosis following etanercept treatment: a report of three cases. Rheumatology International. 1049-1053.
  • Show author(s) (2012). Association between genetic variants in the tumour necrosis factor/lymphotoxin alpha/lymphotoxin beta locus and primary Sjogren's syndrome in Scandinavian samples. Annals of the Rheumatic Diseases. 981-988.
  • Show author(s) (2011). The point prevalence of clinically relevant primary Sjögren's syndrome in two Norwegian counties. Scandinavian Journal of Rheumatology. 221-224.
  • Show author(s) (2011). Salmon diet in patients with active ulcerative colitis reduced the simple clinical colitis activity index and increased the anti-infl ammatory fatty acid index – a pilot study. Scandinavian Journal of Clinical and Laboratory Investigation. 68-73.
  • Show author(s) (2011). Potential association of muscarinic receptor 3 gene variants with primary Sjögren's syndrome. Annals of the Rheumatic Diseases. 1327-1329.
  • Show author(s) (2011). Migraine is frequent in patients with systemic lupus erythematosus: A case-control study. Cephalalgia. 401-408.
  • Show author(s) (2011). Churg-Strauss syndrome successfully treated with rituximab. Rheumatology International. 89-91.
  • Show author(s) (2011). Association of EBF1, FAM167A(C8orf13)-BLK and TNFSF4 gene variants with primary Sjögren's syndrome. Genes and Immunity. 100-109.
  • Show author(s) (2010). Thrombotic microangiopathy and the antiphospholipid syndrome. Lupus. 1569-1572.
  • Show author(s) (2010). No effect of supplementation with cholecalciferol on cytokines and markers of inflammation in overweight and obese subjects. Cytokine. 175-180.
  • Show author(s) (2009). Neuropsychiatric syndromes in patients with systemic lupus erythematosus and primary Sjögren syndrome: a comparative population-based study. Annals of the Rheumatic Diseases. 1541-1546.
  • Show author(s) (2009). Neuropsychiatric Lupus and Association with Cerebrospinal Fluid immunoglobulins: A Pilot Study. Israel Medical Association Journal. 359-362.
  • Show author(s) (2009). Fatigue in primary Sjogren's syndrome - A link to sickness behaviour in animals? Brain, Behavior, and Immunity. 1104-1108.
  • Show author(s) (2009). Cerebral white matter hyperintensities are not increased in patients with primary Sjögren's syndrome. European Journal of Neurology. 576-581.
  • Show author(s) (2008). Neuropsychiatric syndromes in patients with Systemic Lupus Erythematosus and primary Sjögrens Syndrome A comparative population-based study. Annals of the Rheumatic Diseases.
  • Show author(s) (2008). Lntravenous cyclophosphamide in patients with chronic systemic inflammatory diseases: morbidity and mortality. Scandinavian Journal of Rheumatology. 130-134.
  • Show author(s) (2008). Intravenous cyclophosphamide in patients with chronic systemic inflammatory diseases: morbidity amd mortality. Scandinavian Journal of Rheumatology. 130-134.
  • Show author(s) (2008). Fatigue is associated with cerebral white matter hyperintensities in patients with systemic lupus erythematosus. Journal of Neurology, Neurosurgery and Psychiatry. 199-201.
  • Show author(s) (2006). Small-diameter nerve fiber neuropathy in systemic lupus erythematosus. Archives of Neurology. 401-404.
  • Show author(s) (2006). Peripheral neuropathy in primary Sjogren syndrome - A population-based study. Archives of Neurology. 1612-1615.
  • Show author(s) (2006). Intraepidermal nerve fiber densities in chronic inflammatory autoimmune diseases. Archives of Neurology. 1410-1413.
  • Show author(s) (2006). Detection of cerebral embolic signals in patients with systemic lupus erythematosus. Journal of Neurology, Neurosurgery and Psychiatry. 774-779.
  • Show author(s) (2005). Neuropsychiatric symptoms in patients with multiple sclerosis. Acta Psychiatrica Scandinavica. 463-468.
  • Show author(s) (2005). Neuropsychiatric disturbances in SLE are associated with antibodies against NMDA receptors. European Journal of Neurology. 392-398.
  • Show author(s) (2005). Fatigue in patients with lupus is not associated with disturbances in cerebral blood flow as detected by SPECT. Journal of Neurology. 78-83.
  • Show author(s) (2005). Anti-CD20 therapy of treatment-resistant Wegener's granulomatosis: favourable but temporary response. Scandinavian Journal of Rheumatology. 229-232.
  • Show author(s) (2004). Wegener's granulomatosis of the prostate gland. Rheumatology International. 120-122.
  • Show author(s) (2004). The effect of interleukin-1 blockade on fatigue in rheumatoid arthritis-a pilot study. Rheumatology International.
  • Show author(s) (2004). The effect of age and gender on epidermal nerve fiber density. Neurology. 774-777.
  • Show author(s) (2004). The effect of age and gender on epidermal nerve fiber density. Neurology. 774-777.
  • Show author(s) (2004). Respiratory arrest in systemic lupus erythematosus due to phrenic nerve neuropathy. Lupus. 817-819.
  • Show author(s) (2003). Wegener's granulomatosis of the prostate gland. Rheumatology. x-x.
  • Show author(s) (2003). Fatigue in patients with systemic lupus erythematosus: the psychosocial aspects. Journal of Rheumatology. 283-287.
  • Show author(s) (2003). Fatigue in patients with systemic lupus erythematosus: The psychosocial aspects. Journal of Rheumatology. 283-287.
  • Show author(s) (2002). Small Nerve Fiber Involvement in Systemic Lupus Erythematosus. A Controlled Study. Arthritis and Rheumatism. 1228-1232.
  • Show author(s) (2002). Neuropsychological function in systemic lupus erythematosus: five-year longitudinal study. Rheumatology (Sveits). 411-415.
  • Show author(s) (2002). Neuropsychological function in systemic lupus erythematosus: a five-year longitudinal study. Rheumatology (Sveits). 411-415.
  • Show author(s) (2002). Fatigue in patients with systemic lupus erythematosus: lack of associations to serum cytokines, antiphospholipid antibodies, or other disease characteristics. Journal of Rheumatology. 482-486.
  • Show author(s) (2002). Fatigue in patients with systemic lupus erythematosus: lack of association to serum cytokines, antiphospholipid antibodies, or other disease characteristics. Journal of Rheumatology. 482-486.
  • Show author(s) (2001). Transesophageal and transthoracic echocardiography and Doppler-examinations in systemis lupus erythematosus. Scandinavian Journal of Rheumatology. 275-281.
  • Show author(s) (2001). Transesophageal and transthoracic echocardiography and Doppler-examinations in systemic lupus erythematosus. Scandinavian Journal of Rheumatology. 275-281.
  • Show author(s) (2001). Somatic and psychological features of headache in systemic lupus erythematosus. Journal of Rheumatology. 772-779.
  • Show author(s) (2001). Somatic and psychological features of headache in systemic lupus erythematosus. Journal of Rheumatology. 772-779.
  • Show author(s) (2001). Peripheral neuropathy in systemic lupus erythematosus -a longitudinal study. Acta Neurologica Scandinavica. 386-391.
  • Show author(s) (2001). Peripheral neuropathy in systemic lupus erythematosus - a longitudinal study. Acta Neurologica Scandinavica. 386-391.
  • Show author(s) (2001). Neuropsychological dysfunction in systemic lupus erythematosus is not associated with changes in cerebral blood flow. Journal of Neurology. 595-602.
  • Show author(s) (2001). Neuropsychological dysfunction in systemic lupus erythematosus is not associated with changes in cerebral blood flow. Journal of Neurology. 595-602.
  • Show author(s) (2001). Hudbiopsi for kvantifisering av intraepidermale nervefibrer. [Skin biopsy for quantification of intraepidermal nerve fibers]. Tidsskrift for Den norske legeforening. 2159-2161.
  • Show author(s) (2001). Hudbiopsi for kvantifisering av intraepidermale nervefibrer. Tidsskrift for Den norske legeforening. 2159-2161.
  • Show author(s) (1999). Cerebral computed tomography and electroencephalography compared with neuropsychological findings in systemic lupus erythematosus. Journal of Neurology. 706-711.
  • Show author(s) (1998). Emotional status in systemic lupus erythematosus. Scandinavian Journal of Rheumatology. 410-414.
  • Show author(s) (1997). Neuropsychological functions in systemic lupus erythematosus: a comparison with chronic whiplash patients. European Journal of Neurology. 171-177.
  • Show author(s) (1996). Nerve Conduction Studies in Rheumatoid Arthritis. Scandinavian Journal of Rheumatology. 287-292.
  • Show author(s) (1996). C-fibre function in systemic lupus erythematosus. Lupus. 613-617.
  • Show author(s) (1995). Mental Health Status in Systemic Lupus Erythematosus. Scandinavian Journal of Rheumatology. 142-145.
  • Show author(s) (1994). Autonomic Function in Systemic Lupus Erythematosus. Lupus. 413-417.
  • Show author(s) (1993). A controlled study of peripheral neuropathy in systemic lupus erythematosus. Acta Neurologica Scandinavica. 41-46.
  • Show author(s) (1991). Peripheral neuropathy in systemic lupus erythematosus. Neurology. 808-811.
  • Show author(s) (1991). Muscular Weakness in Systemic Lupus Erythematosus. Journal of Rheumatology. 1364-1367.
  • Show author(s) (1990). Sentralnervøse symptomer og funn hos pasienter med systemisk lupus erythematosus. Tidsskrift for Den norske legeforening. 2649-2651.
  • Show author(s) (1990). Nevromuskulære symptomer og funn ved systemisk lupus erythematosus. Tidsskrift for Den norske legeforening. 2652-2653.
  • Show author(s) (1989). Clinical Neurological, Electrophysiological, and Cerebral CT Scan Findings in Systemis Lupus Erythematosus. Scandinavian Journal of Rheumatology. 283-289.
  • Show author(s) (1988). Clinical Neuropsychiatric and Neuromuscular Manifestations in Systemic Lupus Erythematosus. Scandinavian Journal of Rheumatology. 113-117.
Academic lecture
  • Show author(s) (2011). Ultrasonographic evaluation of DSS-induced colitis in rats after dietary intake of a modified thia fatty acid.
  • Show author(s) (2002). Vaskulitt for nevrologer.
  • Show author(s) (2002). The variability of epidermal nerve fiber densities in healthy individuals.
  • Show author(s) (2002). Systemisk lupus erythematosus.
  • Show author(s) (2002). SLE – a headache.
  • Show author(s) (2002). Nye behandlingsprinsipper for reumatiske lidelser.
  • Show author(s) (2002). Determination of epidermal nerve fiber density. Methodological issues.
  • Show author(s) (2001). Tynnfibernevropati ved SLE - en kontrollert studie.
  • Show author(s) (2001). Tynnfiber-nevropati ved systemisk lupus erythematosus (SLE).
  • Show author(s) (2001). Fatigue ved SLE er ikke assosiert med serum cytokiner, antistoffer mot fosfolipider eller andre sykdomskarakteristika.
Editorial
  • Show author(s) (2002). Some controversies of neuropsychiatric systemic lupus erythematosus. Scandinavian Journal of Rheumatology. 192-197.
Feature article
  • Show author(s) (2004). Fatigue and psychological states in SLE: association or causation? Rheumatology (Sveits). 823.
Doctoral dissertation
  • Show author(s) (2016). Headache in systemic lupus erythematosus and Sjögren's syndrome.
  • Show author(s) (2015). Cognitive dysfunction in autoimmune diseases.
  • Show author(s) (2009). Neuropsychiatric manifestations and fatigue in systemic lupus erythematosus and primary Sjøgren's syndrome.
  • Show author(s) (2006). Small-diameter nerve fiber neuropathy in patients with systemic autoimmune diseases.
Academic chapter/article/Conference paper
  • Show author(s) (2016). Fatigue, pain, and quality of life. 10 pages.
Abstract
  • Show author(s) (2015). Fatigue in Primary Sjögrens Syndrome : A Proteomic Study of Cerebrospinal Fluid. Scandinavian Journal of Immunology. 347-347.
  • Show author(s) (2013). The NKp30/B7H6 Axis Contributes To Pathogenesis In Primary Sjogren's Syndrome. Arthritis and Rheumatism. S1185-S1185.
  • Show author(s) (2013). Complex Functional Effects Within The HLA Contribute To Sjogren's Syndrome Pathogenesis and May Influence Both Transcriptional Regulation and Peptide Binding. Arthritis and Rheumatism. S1184-S1185.
  • Show author(s) (2012). No association of primary Sjögren's Syndrome with Fc gamma? Receptor gene variants. Scandinavian Journal of Immunology. 198-198.
  • Show author(s) (2012). Genetic Variation in the NCR3 Locus Is Associated with Anti-SSA/SSB Positive Primary Sjogren's Syndrome in Scandinavian Samples. Arthritis and Rheumatism. S228-S228.
  • Show author(s) (2012). A Genome-Wide Association Study Establishes Muliple Susceptibility Loci for Sjogren's Syndrome. Arthritis and Rheumatism. S1133-S1133.
  • Show author(s) (2011). Triple X Syndrome (47,XXX) Increases the Risk and Accelerates the Onset of Systemic Lupus Erythematosus and Sjogren's Syndrome: Support for a Gene-Dose Effect From the X Chromosome. Arthritis and Rheumatism. S251-S251.
  • Show author(s) (2011). Large-Scale, High-Density Genotyping Performed by the Sjogren's Genetics Network Using the ImmunoChip Identifies PRKRA as a Novel Sjogren's Syndrome Susceptibility Locus and Confirms Associations with IRF5, BLK and MHC. Arthritis and Rheumatism. S303-S304.
  • Show author(s) (2011). A High-Density Genome-Wide Association Study by the Sjogren's Genetics Network Identifies Five Novel Susceptibility Loci for Primary Sjogren's Syndrome and Confirms Association with MHC, IRF5, and BLK. Arthritis and Rheumatism. S184-S184.
  • Show author(s) (2010). Prevalence of primary Sjogren's syndrome in two Norwegian counties. Scandinavian Journal of Rheumatology. 36-36.
  • Show author(s) (2010). Pattern of mild cognitive impairment in patients with primary Sjogren's syndrome as compared to patients with SLE. Journal of Neuroimmunology. 185-186.
  • Show author(s) (2010). Improvement of fatigue by interleukin-1 inhibition. Journal of Neuroimmunology. 42-42.
  • Show author(s) (2010). Gene Variants in Fam167A-Blk and Tnfsf4 are associated with Primary Sjogren's Syndrome. Scandinavian Journal of Rheumatology. 32-32.
  • Show author(s) (2010). Fc gamma receptor IIA, IIIA and IIIB single nucleotide polymorphisms and Fc gamma receptor IIIB copy number variation: No association with primary Sjögren's syndrome. Scandinavian Journal of Rheumatology. 36-36.
  • Show author(s) (2010). Association between Lymphotoxin Alpha Genetic Variants and Primary Sjögren`s Syndrome in Scandinavian Samples. Arthritis and Rheumatism. 788-789.
  • Show author(s) (2005). The spectrum of peripheral neuropathy in primary Sjögren's syndrome. Journal of the peripheral nervous system. 28-28.
  • Show author(s) (2005). The spectrum of peripheral neuropathy in primary Sjogren's syndrome. Journal of the peripheral nervous system.
  • Show author(s) (2005). A selective loss of small-diameter nerve fibers in systemic lupus erythematosus. Journal of the peripheral nervous system.
  • Show author(s) (2004). Small-fiber neuropathy in systemic lupus erythematosus. Journal of Neuroimmunology. 146.
  • Show author(s) (2004). Anti-NR2 glutamate receptor antibodies in systemic lupus erythematosus - associations with clinical findings. Journal of Neuroimmunology. 138.
  • Show author(s) (2003). Epidermal nerve fiber density. Effect of age and gender. Neurology. A387.
Errata
  • Show author(s) (2023). Author Correction: Genome-wide association study identifies Sjögren’s risk loci with functional implications in immune and glandular cells (Nature Communications, (2022), 13, 1, (4287), 10.1038/s41467-022-30773-y). Nature Communications.
  • Show author(s) (2022). Erratum: Author Correction: Genome-wide association study identifies Sjögren's risk loci with functional implications in immune and glandular cells (Nature communications (2022) 13 1 (4287)). Nature Communications. 6519.
  • Show author(s) (2018). Corrigendum to "Klinefelter's syndrome (47,XXY) is in excess among men with Sjögren's syndrome". Clinical Immunology. 137-138.
Academic literature review
  • Show author(s) (2023). The Effect of Biological Treatment on Fatigue in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. Drugs. 909-921.
  • Show author(s) (2020). The biological basis of chronic fatigue: neuroinflammation and innate immunity. Current Opinion in Neurology. 391-396.
  • Show author(s) (2019). Primary Sjögren's syndrome and the eye. Survey of ophthalmology. 119-132.
  • Show author(s) (2019). Pain and fatigue in primary Sjögren's syndrome. Rheumatology. 3099-3106.
  • Show author(s) (2019). Fatigue in celiac disease: A review of the literature. Journal of Gastroenterology and Hepatology Open (JGH Open). 242-248.
  • Show author(s) (2019). Effect of biological treatment on fatigue in psoriasis: A systematic review and meta-analysis. American Journal of Clinical Dermatology. 493-502.
  • Show author(s) (2015). Fatigue in psoriasis: a phenomenon to be explored. British Journal of Dermatology. 1196-1203.
  • Show author(s) (2013). Is it safe to use TNF-α blockers for systemic inflammatory disease in patients with heart failure? Importance of dosage and receptor specificity. International Journal of Cardiology. 1719-1723.
  • Show author(s) (2012). Systemic lupus erythematosus, the brain, and anti-NR2 antibodies. Journal of Neurology. 622-629.
  • Show author(s) (2012). Infeksjonsrisiko ved bruk av selektivt immunmodulerende midler mot revmatoid artritt. Tidsskrift for Den norske legeforening. 1867-1871.
  • Show author(s) (2011). Memantine in Systemic Lupus Erythematosus: A Randomized, Double-Blind Placebo-Controlled Trial. Seminars in Arthritis & Rheumatism. 194-202.
  • Show author(s) (2011). Biological mechanisms of chronic fatigue. Review series. Rheumatology. 1009-1019.
  • Show author(s) (2010). Intravenøs IgG-behandling av nevromuskulære sykdommer :. Tidsskrift for Den norske legeforening. 1717-1720.
  • Show author(s) (2008). Anti-CD20 treatment in Primary Sjogren's Syndrome. Scandinavian Journal of Immunology. 554-564.
  • Show author(s) (2007). Primary Sjögren´s Syndrome Associated Neuropathy. Canadian Journal of Neurological Sciences (CJNS). 280-287.
Article in business/trade/industry journal
  • Show author(s) (2018). Kronisk fatigue - ei utfordring i klinisk praksis. Utposten. 7-9.

More information in national current research information system (CRIStin)